RecruitingACTRN12613000580774

The Maternal Pertussis Randomised Control Trial: best practice for the communication of pertussis booster vaccine recommendations to new mothers.

The influence of baseline attitudes, modifiable factors and health message framing on whooping cough booster vaccine uptake among new mothers on the postnatal ward.


Sponsor

Associate Professor John Sinn

Enrollment

1,080 participants

Start Date

Mar 26, 2012

Study Type

Interventional

Conditions

Summary

The cocooning strategy, which was implemented in Australia in 2009, can have a strong protective effect (indirect) against pertussis in infants. To achieve high maternal coverage, understanding maternal attitudes and other potentially influential factors is important. In this study, we examined the influence of baseline attitudes, modifiable factors and health message framing on pertussis booster vaccine uptake among postpartum women in the hospital setting.


Eligibility

Sex: FemalesMin Age: 18 Yearss

Inclusion Criteria1

  • Postpartum women not up to date with pertussis booster recommendations ( dTpa <10 years)

Exclusion Criteria2

  • Requires an interpreter.
  • Unable to given written informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Health-message framing: The tri-fold, coloured A4 pamphlet was written either in a gain or loss frame, indicating either what mothers gain from the cocooning strategy or what mothers would lose by not

Health-message framing: The tri-fold, coloured A4 pamphlet was written either in a gain or loss frame, indicating either what mothers gain from the cocooning strategy or what mothers would lose by not receiving the pertussis booster vaccine (for adults). The intervention was administered by the research nurse once the baseline questionnaire was completed. Allocation concealment was implement by placing the pamphlet in an opaque envelope. The interventions ( gain or loss pamphlet) were allocated to participants using random block allocation by week.


Locations(1)

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12613000580774


Related Trials